Physician

Emma Coleen Mcdonnell

According to 2025 Medicare claims, Emma Mcdonnell (NPI: 1023357670) practices ophthalmology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is CALIFORNIA RETINA ASSOCIATES, LP (NPI: 1114033404; TIN: 330298426) and primary practice location at 91911-1352.

Mcdonnell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 782 traditional Medicare patients, billed 4,941 HCPCS/CPT codes, and received $276,442 in Medicare payments. The top billing code was 15823 (Removal of excessive skin and fat of upper eyelid). Part D data shows 1,501 prescription claims across 648 beneficiaries totaling $107,230 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 16 records totaling $668. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,980 to $276,442. Similarly, Part D prescription costs have risen steadily, from $1,566 to $107,230. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$164K$327K2019 Medicare payment: $11,980 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $22,921 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $121,242 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $284,442 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $327,439 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $276,442 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195670$11,980
2020102136$22,921
2021368841$121,242
20227472,203$284,442
20238024,094$327,439
20247824,941$276,442

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$54K$107K2015 Drug cost: $1,566 (USD; Tot_Drug_Cst)2016 Drug cost: $7,090 (USD; Tot_Drug_Cst)2017 Drug cost: $20,680 (USD; Tot_Drug_Cst)2018 Drug cost: $14,916 (USD; Tot_Drug_Cst)2019 Drug cost: $8,609 (USD; Tot_Drug_Cst)2020 Drug cost: $6,399 (USD; Tot_Drug_Cst)2021 Drug cost: $10,664 (USD; Tot_Drug_Cst)2022 Drug cost: $41,434 (USD; Tot_Drug_Cst)2023 Drug cost: $65,635 (USD; Tot_Drug_Cst)2024 Drug cost: $107,230 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R17$1,566
201637162$7,090
201786461$20,680
201839161$14,916
201980165$8,609
2020124213$6,399
2021233371$10,664
20225361,005$41,434
20236481,249$65,635
20246481,501$107,230

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
15823Removal of excessive skin and fat of upper eyelid124124$709
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more192205$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9396$68
92012Established patient problem focused exam of visual system494611$66
92285Photography of content of eyes477520$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CyclosporineCyclosporine984,380$35,056
RestasisCyclosporine411,590$29,023
XiidraLifitegrast13690$14,601
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha71711,033$8,163
ErythromycinErythromycin Base3536,439$3,777

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$668Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Emma Coleen Mcdonnell?

Tedicare shows public-source Medicare data for Emma Coleen Mcdonnell (NPI 1023357670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emma Coleen Mcdonnell have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emma Coleen Mcdonnell?

Emma Coleen Mcdonnell is linked to CALIFORNIA RETINA ASSOCIATES, LP (billing NPI 1114033404) in the available physician profile data.

Does Emma Coleen Mcdonnell have Open Payments data?

Emma Coleen Mcdonnell has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.